(19)
(11) EP 1 501 805 A1

(12)

(43) Date of publication:
02.02.2005 Bulletin 2005/05

(21) Application number: 03716793.9

(22) Date of filing: 19.03.2003
(51) International Patent Classification (IPC)7C07D 231/54, A61K 31/416, A61P 29/00, C07D 401/12, C07D 413/12, C07D 403/12, C07D 409/14, C07D 417/12, C07D 409/12, C07D 405/14, C07D 405/12, C07D 405/10, C07D 401/14
(86) International application number:
PCT/US2003/008917
(87) International publication number:
WO 2003/095430 (20.11.2003 Gazette 2003/47)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated Extension States:
AL LT LV MK

(30) Priority: 09.05.2002 US 379090 P
19.09.2002 WO PCT/US02/29774

(71) Applicant: Pharmacia Corporation
St. Louis, MO 63006 (US)

(72) Inventors:
  • LENNON, Patrick
    Webster Groves, MO 63119 (US)
  • BONAFOUX, Dominique
    St. Louis, MO 63130 (US)
  • OBURN, David, S.
    Ferguson, MO 63135 (US)
  • WOLFSON, Serge, G.
    Chesterfield, MO 63017 (US)

(74) Representative: Motion, Keith Robert et al
Pfizer Limited,European Pharma Patent Department,Ramsgate Road
Sandwich,Kent CT13 9NJ
Sandwich,Kent CT13 9NJ (GB)

   


(54) SUBSTITUTED PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION